ClinicalTrials.gg
RecruitingNCT07320066IMT in AsthmaUpdated Jan 9, 2026

IMT in Asthma: Activity, Coping, Self-Management

An observational study in Qualitative Research, sponsored by Istanbul Esenyurt University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-01-09.

Sponsored by Istanbul Esenyurt University · Observational

How we know

From the registry’s dates

  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
15
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 133 studies in Asthma with a site in Turkey — 16 open to participants now, 21 under way, 5 of them phase 3. Asthma · Turkey.

Planned enrollment
20th of 21
15 · median 95
Started
2026
with 10 others
Observational
21 of 133
3 open now
Primary completion
2027-01
later than 8 of 20 live
Registered
119th of 133
by date

Among the 133 studies in Asthma with a site in Turkey, this one is the 20th largest by planned enrollment of the 21 observational ones that give a count, is one of 11 that started in 2026, is one of 21 observational ones, reaches primary completion later than 8 of the 20 other live ones, and was the 119th registered.

Asthma

4,850 studies on the registry are indexed under Asthma; 604 are open to participants now.

Browse Asthma studies →

Open to participants now

16 of the 133 studies in Asthma with a site in Turkey are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 416 Asthma studies recruiting now, 141 (34%) set no upper age limit and 204 (49%) stop at 75 or younger; 146 take children under 18; 105 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 133 studies in Asthma with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this study is to investigate asthma patients' experiences with an 8 week IMT and the perceived effects of this intervention on physical activity, coping strategies, and asthma self-management. A qualitative methodological design will be applied to understand the experiences of patients participating in the IMT program, how the program affected their daily activities, how they coped with symptoms and difficulties, and how they managed their condition.

Read the detailed description

The study will include patients diagnosed with asthma by a chest disease specialist and referred for pulmonary rehabilitation. Cases meeting the inclusion criteria will be questioned about the effects of their previous experience with COPD on their daily lives, their coping strategies, and their self-management processes. Therefore, it is determined as a basic criterion that participants have received IMT training for 8 weeks, 2 days a week via video conference and 1 day within the home program, for a total of 3 days a week. IMT should be performed in 7 sets, consisting of 2 minutes of work and 1 minute of rest, for a total of 21 minutes. Five main themes were identified as a result of data analysis. (a) Inspiratory Muscle Training and Participant Experiences (b) Experience of Exercising with Telerehabilitation (c) Changes in Physical Activity Levels (d) Self-Management Skills and (e) Coping Strategies.

03

Conditions studied

  • Qualitative Research

Browse trials for

Keywords

  • asthma
  • inspiratory muscle training
  • telerehabilitation
  • self-management
  • qualitative research
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Asthma

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being between the ages of 18-65
  • Having been diagnosed with severe persistent, non-allergic asthma by a pulmonologist in accordance with the Global Initiative for Asthma (GINA) guideline criteria,
  • Patients with type 2 inflammation markers. According to accepted standards; peripheral eosinophils \<150/µL and/or negative skin prick test and/or total IgE \<30 kU/L
  • Bronchodilator response (>12% or 200 mL improvement in % predicted following inhalation of 400 mg salbutamol)
  • Diagnosis-follow-up period: Patients diagnosed at least 6 months prior, under follow-up and treatment, and/or with controlled asthma
  • Having completed the pulmonary rehabilitation program
  • Completion of 8 weeks of inspiratory muscle training (IMT)
  • Patients who have read, understood, and signed the form

Exclusion criteria

Exclusion Criteria:

  • Having recently had a respiratory tract infection recently (within the last month),
  • Having a smoking history of more than 10 pack-years or having a history of smoking within 6 months after quitting smoking
  • Having received oral treatment in the last 4 weeks,
  • Having a >35,
  • Eosinophilic Granulomatosis Polyangiitis (EGPA) and Allergic Bronchopulmonary Aspergillosis (ABPA),
  • Vasculitis,
  • History of ,
  • Pregnancy,
  • Previous lung surgery, use of long-term oxygen therapy
  • Having accompanying restrictive lung diseases (advanced kyphoscoliosis, ankylosing spondylitis) and neuromuscular diseases (myastania gravis, muscular dystrophies, myopathies) that will prevent healthy respiratory function testing and rehabilitation.
  • Cognitive dysfunction, mental retardation, dementia, or other conditions that make it difficult to follow the protocol,
  • Unwillingness to continue participating in the study,
  • Communication difficulties or intellectual deficiencies
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

FEV1

From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Other
Time perspective
Other
Enrollment
15 participants (estimated)
Patient registry
No

Groups and cohorts

  • Pulmonary Rehabilitation Group (PRGr)

    Pulmonary Rehabilitation Group (PRGr) Participant selection for the study was conducted using a purposive sampling approach. All participants experienced inspiratory muscle training for a total of 3 days per week over 8 weeks, with 2 days per week via video conference and 1 day per week as part of a home program. All interviews will be conducted online via a video conference website and recorded using a digital voice recorder. The recorded data will be transcribed word for word in Turkish.

    Other: other

Interventions

  • Otherother

    Other: Telephone concept elicitation interview All interview questions are designed to be quite open-ended in order to determine participants' preferences in an unbiased manner (as much as possible). Additional questions will only be used when necessary to ensure that all relevant concepts are covered. Participants will be asked questions about the effects of inspirational muscle training they have previously experienced on their daily lives, coping strategies, and self-management processes.

06

What researchers measure

Primary outcomes

  1. Patient-reported experiences of inspiratory muscle training (IMT) assessed by semi-structured in-depth interviews (study-specific interview guide)

    Semi-structured, in-depth, audio-recorded interviews will be conducted using a study-specific interview guide containing open-ended questions to investigate the effect of an 8-week inspiratory muscle training (IMT) program on the experiences of adults with severe persistent asthma. Interviews will be conducted online and, when possible, in person or via telephone/video call. Interviews are expected to last approximately 45-60 minutes. Recordings will be transcribed verbatim in Turkish, supplemented with the researcher's field notes, and analyzed using thematic analysis.

    Time frame: Single assessment after completion of the 8-week IMT program (within 4 weeks after IMT completion)

  2. Experience of exercising using telerehabilitation assessed by semi-structured in-depth interviews (study-specific interview guide)

    Semi-structured, in-depth, audio-recorded interviews will be conducted using a study-specific interview guide with open-ended questions to explore participants' experiences of exercising with telerehabilitation, including the perceived role of telerehabilitation in the learning process, and perceived advantages, limitations, and challenges from the participant's perspective. Interviews will be conducted online and, when possible, in person or via telephone/video call. Interviews are expected to last approximately 45-60 minutes. Recordings will be transcribed verbatim in Turkish, supplemented with the researcher's field notes, and analyzed using thematic analysis.

    Time frame: Single assessment after completion of the 8-week IMT program (within 4 weeks after IMT completion)

  3. Changes in physical activity in daily life assessed by semi-structured in-depth interviews (study-specific interview guide)

    Semi-structured, in-depth, audio-recorded interviews will be conducted using a study-specific interview guide with open-ended questions to explore perceived changes in physical activity in daily life (e.g., walking, climbing stairs, housework) from the participant's perspective following the 8-week program. Interviews will be conducted online and, when possible, in person or via telephone/video call. Interviews are expected to last approximately 45-60 minutes. Recordings will be transcribed verbatim in Turkish, supplemented with the researcher's field notes, and analyzed using thematic analysis.

    Time frame: Single assessment after completion of the 8-week IMT program (within 4 weeks after IMT completion)

  4. Self-management skills assessed by semi-structured in-depth interviews (study-specific interview guide)

    Semi-structured, in-depth, audio-recorded interviews will be conducted using a study-specific interview guide with open-ended questions to explore participants' perceived self-management skills, including disease and trigger recognition, symptom monitoring, accountability/responsibility, and perceived control. Interviews will be conducted online and, when possible, in person or via telephone/video call. Interviews are expected to last approximately 45-60 minutes. Recordings will be transcribed verbatim in Turkish, supplemented with the researcher's field notes, and analyzed using thematic analysis.

    Time frame: Single assessment after completion of the 8-week IMT program (within 4 weeks after IMT completion)

  5. Coping strategies assessed by semi-structured in-depth interviews (study-specific interview guide)

    Semi-structured, in-depth, audio-recorded interviews will be conducted using a study-specific interview guide with open-ended questions to explore participants' perceived coping strategies, including breathing/respiratory rate control strategies and emotional and behavioral regulation during symptom attacks and when anxiety/panic symptoms are prominent. Interviews will be conducted online and, when possible, in person or via telephone/video call. Interviews are expected to last approximately 45-60 minutes. Recordings will be transcribed verbatim in Turkish, supplemented with the researcher's field notes, and analyzed using thematic analysis.

    Time frame: Single assessment after completion of the 8-week IMT program (within 4 weeks after IMT completion)

07

Study locations

1 of 1 sites recruiting
  • Istanbul Esenyurt University
    Istanbul, Istanbul 34890, Turkey (Türkiye)
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Jan 2027, 11 months after the start.

Of 366 non-industry observational studies under Asthma, half reached primary completion within 38 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 97. This study's planned 11 months is below that.

Counting every sponsor, half of 456 studies reached it within 36 months; a quarter within 18 and three quarters within 82.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 9, 2025
First posted
Jan 6, 2026
StartActual
Jan 5, 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
Dec 19, 2027
Last update
Jan 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07320066
Lead sponsor
Istanbul Esenyurt University
Responsible party
Cahidenur Koçak (Principal investigator, Saglik Bilimleri Universitesi) — Principal investigator
First posted
Jan 6, 2026
Start date
Jan 5, 2026
Primary completion
Jan 1, 2027 (estimated)
Completion
Dec 19, 2027 (estimated)
Last update
Jan 9, 2026

Study contacts

Esra PEHLİVAN, PhD
Contact
fztesrakambur@yahoo.com
+90 216 777 96 00

Oversight

Data monitoring committee
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion